Skip to main content

Table 1 ACR indicates American College of Rheumatology; AJC, active joint count; DI-CHAQ, disability index of childhood health assessment questionnaire; PaGA, parent global assessment of well-being; PhyGA, physician’s global assessment of disease activity.

From: Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

Time points ACR 30/50/70/90 PhyGA PaGA AJC DI-CHAQ
Week 16 100/88/63/39 12.7 12.2 5.1 0.4
Week 48 100/96/92/69 6.3 8.3 2.9 0.2
Week 106 100/96/96/71 5.9 5.0 1.2 0.1
  1. % of Pts Aged 4-12 Years Achieving ACR Pedi and Mean Values in Disease Activity/Severity Variables by ADA Exposure Throughout the Study